arrow
Back
A

Alberico L. Catapano

irccs multimedica

123H-index
1.3KPaper Count
13.5WCitation Count
Published Papers 515
Publication Date
Lipids and abdominal aortic aneurysm: from pathophysiology to therapy. A call to action from SISA and SIAPAV
err2026-07-01
err0
PREAI
errRossella Marcucci; Marco Bucci; Walter Ageno; Marcello Arca; Maurizio Averna; Carlo M. Barbagallo; Alberto Corsini; Giuliana Fortunato; Francesca Ghirardini; Matteo Pirro; Patrizia Suppressa; Paolo Zamboni; Maria Grazia Zenti; Romeo Martini; Alberico L. Catapano; Laura D'Erasmo; Luigi Gentile
errShare
errSave
Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry
err2026-05-18
err0
PREAI
errWillemijn A M Schonck; Janneke W C M Mulder; Marina Cuchel; Laurens F Reeskamp; Fahad Alnouri; Iulia Iatan; Tomas Freiberger; Meral Kayıkçıoğlu; Tycho R Tromp; M Doortje Reijman; Albert Wiegman; G Kees Hovingh; Jeanine E Roeters van Lennep; Frederick J Raal; Dirk J Blom; Alberico L Catapano
errShare
errSave
ARE WE UNDERESTIMATING THE BENEFITS OF LIPID-LOWERING THERAPIES?
err2026-05-08
err0
PREAI
errAngela Pirillo; Manuela Casula; Elena Olmastroni; Stefano Scotti; Alberto Corsini; Alberico L. Catapano
errShare
errSave
Author Correction: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial
err2026-04-17
err0
PREAI
errStephen J. Nicholls; Adam J. Nelson; Marc Ditmarsch; John J. P. Kastelein; Christie M. Ballantyne; Kausik K. Ray; Ann Marie Navar; Steven E. Nissen; Anne C. Goldberg; Liam R. Brunham; Erin Wuerdeman; Annie L. Neild; Douglas Kling; Andrew Hsieh; Julie Butters; Brian A. Ference; Ulrich Laufs; Maciej Banach; Roxana Mehran; Alberico L. Catapano; Michael Szarek; Violeta Balinskaite; Michael H. Davidson
errShare
errSave
CX3CR1-T280M polymorphism and end-stage renal disease development in chronic kidney disease
err2026-04-03
err0
errOAAI
errMatteo Gatti; Ivano Baragetti; Andrea Baragetti; Laura Buzzi; Andrea Lupi; Angelo Fassio; Elena Olmastroni; Alberico L. Catapano; Paolo Fabbrini
errShare
errSave
Oral PCSK9 Inhibitor Enlicitide versus Oral Non-statin Therapies: A Phase 3 Randomized Clinical Trial
errJACC
IF0
err2026-03-30
err0
PREAI
errAlberico L. Catapano; Elina Mikhailova; Ann Marie Navar; Puja Banka; Pablo Corral; Manish Saxena; P.Gabriel Steg; Subodh Verma; Andrew Yacoub Kordahi; Geraldine Mendizabal; Pengfei Zhu; Christie M. Ballantyne
errShare
errSave
Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial
err2026-02-27
err0
PREAI
errStephen J. Nicholls; Adam J. Nelson; Marc Ditmarsch; John J. P. Kastelein; Christie M. Ballantyne; Kausik K. Ray; Ann Marie Navar; Steven E. Nissen; Anne C. Goldberg; Liam R. Brunham; Erin Wuerdeman; Annie L. Neild; Douglas Kling; Andrew Hsieh; Julie Butters; Brian A. Ference; Ulrich Laufs; Maciej Banach; Roxana Mehran; Alberico L. Catapano; Michael Szarek; Violeta Balinskaite; Michael H. Davidson
errShare
errSave
Lipid-lowering therapy and LDL cholesterol control among high- and very high-risk patients in Portugal: An analysis of the SANTORINI study
err2026-02-01
err1
errOAAI
errAguiar, Carlos; Aguiar, Patricio; Duarte, Joao Sequeira; Gil, Victor; Mimoso, Jorge; Monteiro, Pedro; Pinto, Fausto J.; Pinto, Fernando; Raposo, Joao; Von Hafe, Pedro; Ruivo, Jorge A.; Teixeira, Carla; Catapano, Alberico L.; Ray, Kausik K.
errShare
errSave
Fibrates : Do They Still Have a Role in Therapy in 2025?
err2025-12-26
err0
PREAI
errAngela Pirillo; Alberto Zambon; Alberico L. Catapano
errShare
errSave
Cardiovascular Prevention in Children, Adolescents, and Young Adults. A Call-to-Action of the Italian Societies of Pediatrics (SIP), Hypertension (SIIA), Study of Atherosclerosis (SISA), and Cardiovascular Prevention (SIPREC)
err2025-12-09
err0
errOAAI
errSimonetta Genovesi; Roberto Volpe; Davide Agnoletti; Simonetta Bellone; Gianni Bona; Manuela Casula; Luigi Gentile; Francesca Saladini; Rino Agostiniani; Agostino Virdis; Alberico L. Catapano; Massimo Volpe; Marco Giussani
errShare
errSave
Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience
err2025-12-01
err0
errOAAI
errCatapano, Alberico L.; Maggioni, Aldo Pietro; Rossi, Francesco; Consolo, Eleonora; Notarianni, Lucia; Agnelli, Giancarlo
errShare
errSave
PORTRAIT Survey: Patient-Centered Overview Related to Treatment Practices in Lipoprotein Apheresis: Italian Investigating Trajectories
err2025-11-01
err0
PREAI
errSbrana, Francesco; Dal Pino, Beatrice; Corciulo, Carmen; Bigazzi, Federico; Casula, Manuela; Catapano, Alberico L.; Medde, Paolo; Sampietro, Tiziana; Zenti, Maria Grazia
errShare
errSave
Not all fibrates are made equal: Learning from biology and clinical trials
err2025-10-29
err0
PREAI
errAlberto Zambon; Bart Staels; Michel Farnier; Michal Vrablik; Alberico L. Catapano
errShare
errSave
Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort
err2025-10-14
err0
PREAI
errMarcello Arca; Paolo Calabrò; Anna Solini; Angela Pirillo; Rosanna Gambacurta; Kausik K. Ray; Alberico L. Catapano
errShare
errSave
The two faces of cholesteryl ester transfer protein inhibitors
err2025-10-13
err0
PREAI
errPirillo, Angelaa; Catapano, Alberico L.b, c
errShare
errSave
Lipid-lowering therapy treatment regimens in high- and very high-risk patients for the prevention of cardiovascular events: results from the Irish cohort of the multinational, observational SANTORINI study
err2025-10-01
err0
PREAI
errRai, Himanshu; Coughlan, John Joseph; O'callaghan, Daniel; Sheahan, Richard; Murphy, Ross; Burke, David; Mcfadden, Eugene; Nolan, Dermot; Colleran, Roisin; Hazeez-Agbaje, Abiola; Ray, Kausik K.; Catapano, Alberico L.; Byrne, Robert A.
errShare
errSave
Predictors and benefits of lipid-lowering therapy initiation after an atherosclerotic cardiovascular event: a retrospective cohort study
err2025-09-26
err0
errOAAI
errManuela Casula; Stefano Scotti; Federica Galimberti; Giacomo Matteo Bruno†; Giorgio Lorenzo Colombo†; Asiiat Alieva; Sining Xie†; Alberico Luigi Catapano; Elena Olmastroni
errShare
errSave
Triglycerides as Determinants of Global Lipoprotein Derangement: Implications for Cardiovascular Prevention
err2025-09-03
err0
errOAAI
errNúria Amigó; Pol Torné; Liv T. Nordestgaard; Francesco Di Giacomo-Barbagallo; Carla Merino; Paolo Magni; Ana González-Lleó; Natalia Andreychuk; Alberico L. Catapano; Lluís Masana; Daiana Ibarretxe
errShare
errSave